Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance - Wikidata - wikimedia - TriplyDB

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

http://www.wikidata.org/entity/Q58563027

about

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

http://www.wikidata.org/entity/Q58563027

description

article publié dans la revue scientifique Scientific Reports

@fr

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Previous antiretroviral drug u ...... diated through drug-resistance

@en

Previous antiretroviral drug u ...... diated through drug-resistance

@nl

type

label

Previous antiretroviral drug u ...... diated through drug-resistance

@en

Previous antiretroviral drug u ...... diated through drug-resistance

@nl

prefLabel

Previous antiretroviral drug u ...... diated through drug-resistance

@en

Previous antiretroviral drug u ...... diated through drug-resistance

@nl

P1433

Q58563027-697E7D83-5137-4EDE-B8A8-78BAF5CC6E59

P1476

Q58563027-2F4A8478-7CA1-4190-94C2-E13975C34B82

P2093

Q58563027-3CB70883-221C-43F5-B3B7-53036F6573AC

Q58563027-4AC4E3A3-43BA-4616-9112-DDDD7648057C

Q58563027-6B60A608-DEB6-4DC0-A323-D7AF05C6AAA7

Q58563027-782394DA-BCE6-479E-A41C-584CACC1C444

Q58563027-7877419C-9F11-4182-9A51-5A21F11863F7

Q58563027-8828D6FE-5B3D-41D5-9210-CF559BC93D24

Q58563027-885379EF-5EDB-4FCD-990F-51C0640CFF81

Q58563027-88C56B5C-F55E-4436-A37D-3015A150F165

Q58563027-899633E4-1211-4EE6-B73C-5A8EE56478EB

Q58563027-94E453BC-809D-4415-AD9B-22A90D1DE0CA

P2860

Q58563027-07DAB135-CB42-42E5-982B-5E8F79B40554

Q58563027-197E24AF-ED18-4096-9ABA-EC3745CE7508

Q58563027-235CED50-397F-47F8-8AB3-9354E78F06BF

Q58563027-306F5FB2-94D1-4E59-B926-B34A821CD482

Q58563027-375ED329-C273-46B7-A05A-419EE9FF8DCB

Q58563027-76319DAD-16A3-4FB6-8F4D-E6FD1DC72824

Q58563027-8323E1CC-29D2-468C-9B87-2AB1358BB164

Q58563027-89CFD547-2751-4F4F-97B2-6AF803CAF82F

Q58563027-957CFC15-A243-4D92-A088-171B78879CB6

Q58563027-B72B93C4-F011-4392-B382-AACDA8CED953

P304

Q58563027-BFAF1641-E69A-43B2-B5F0-52A334EDCCF4

P31

Q58563027-48229F55-2110-497F-A618-C39EC5D38F9F

P356

Q58563027-99AF158D-50D1-466F-AFDE-0ECDEFEB90D7

P407

Q58563027-63660375-4E57-429B-802E-8607AF146C01

P433

Q58563027-0A52B724-329E-4698-9987-6C6CC0F2E9BA

P478

Q58563027-F2E67278-C882-41A0-A598-312DA52D2881

P50

Q58563027-16879704-5B99-403B-9748-727F8132BAAD

Q58563027-2BCEC718-2214-4F29-90B8-685314D522A2

Q58563027-6A74507A-6A97-4C12-8DB4-E77CA15122A8

P577

Q58563027-7DD4F886-3868-4269-BA23-6A60BDF853B9

P698

Q58563027-8E22F7BC-9C88-49D1-87FD-2FAED22B0494

P932

Q58563027-4967C780-CDE5-40F4-8D4E-2E13D1DCFE83

P356

S41598-018-33538-0

P1433

Scientific Reports

P1476

Previous antiretroviral drug u ...... diated through drug-resistance

@en

P2093

Cissy M Kityo

http://www.w3.org/2001/XMLSchema#string

Kim C E Sigaloff

http://www.w3.org/2001/XMLSchema#string

Kishor Mandaliya

http://www.w3.org/2001/XMLSchema#string

Margaret Siwale

http://www.w3.org/2001/XMLSchema#string

Marleen de Jager

http://www.w3.org/2001/XMLSchema#string

Maureen Wellington

http://www.w3.org/2001/XMLSchema#string

Pascale Ondoa

http://www.w3.org/2001/XMLSchema#string

Prudence Ive

http://www.w3.org/2001/XMLSchema#string

Raph L Hamers

http://www.w3.org/2001/XMLSchema#string

Seth C Inzaule

http://www.w3.org/2001/XMLSchema#string

P2860

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.

Predictors of raised viral load during antiretroviral therapy in patients with and without prior antiretroviral use: a cross-sectional study.

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.

Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

2017 Update of the Drug Resistance Mutations in HIV-1.

P304

15751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-33538-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Tamara Sonia Boender

Alani Sulaimon Akanmu

P577

2018-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30361640

http://www.w3.org/2001/XMLSchema#string

P932

6202366

http://www.w3.org/2001/XMLSchema#string